Enthesitis-Related arthritis (juvenile ankylosing spondylitis)

Textbook of Pediatric Rheumatology

Volumn , Issue , 2011, Pages 272-286

  Petty, Ross E ^c   Cassidy, James T ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82755163338     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6581-4.10017-2     Document Type: Chapter

References (255)

1. Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J. Rheumatol. 2004, 31:390-392.
2. Bennett P.H., Wood P.H.N. Population studies of the Rheumatic Diseases 1968, Excerpta Medica, New York.
3. Amor B., Dougados M., Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev. Rhum. Mal. Osteoartic. 1990, 57:85-89.
4. Dougados M., van der Linden L.S., Juhlin R., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy,. Arthritis Rheum. 1991, 34:1218-1227.
5. Wright V., Moll J.M. Seronegative polyarthritis 1976, North Holland, Amsterdam, The Netherlands.
6. Rosenberg A.M., Petty R.E. A syndrome of seronegative enthesopathy and arthropathy in children,. Arthritis Rheum. 1982, 25:1041-1047.
7. Fink C.W. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J. Rheumatol. 1995, 22:1566-1569.
8. Petty R.E., Southwood T.R., Baum J., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban. J. Rheumatol. 1997, 25:1991-1994. 1998.
9. Cabral D.A., Oen K.G., Petty R.E. SEA syndrome revisited: a longterm followup of children with a syndrome of seronegative enthesopathy and arthropathy. J. Rheumatol. 1992, 19:1282-1285.
10. Burgos-Vargas R., Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J. Rheumatol. 1989, 16:192-197.
11. Prieur A.M., Listrat V., Dougados M., et al. Criteria for classification of spondylarthropathies in children. Arch. Fr. Pediatr. 1993, 50:379-385.
12. Bowyer S., Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J. Rheumatol. 1996, 23:1968-1974.
13. Malleson P.N., Fung M.Y., Rosenberg A.M. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry,. J. Rheumatol. 1996, 23:1981-1987.
14. Symmons D.P., Jones M., Osborne J., et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J. Rheumatol. 1996, 23:1975-1980.
15. Sauernmann R.K., Rose J.B., Tyrell P., et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 2007, 56:974-1984.
16. Ladd J.R., Cassidy J.T., Martel W. Juvenile ankylosing spondylitis. Arthritis Rheum. 1971, 14:579-590.
17. Schaller J., Bitnum S., Wedgwood R.J. Ankylosing spondylitis with childhood onset. J. Pediatr. 1969, 74:505-516.
18. Hafner R. Juvenile spondarthritis: retrospective study of 71 patients. Monatsschr. Kinderheilkd. 1987, 135:41-46.
19. Kim T.-H., Uhm W.-S., Inman R.D. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr. Opin. Rheumatol. 2005, 17:400-405.
20. Pham T. Pathophysiology of ankylosing spondylitis: what's new?. Joint. Bone Spine 2008, 75:656-660.
21. Sieper J. Developments in the scientific and clinical understanding of the spondyloarthritides. Arthritis Res. Therapy 2009, 11:208.
22. Reveille J.D. The genetic basis of ankylosing spondylitis,. Curr. Opin. Rheumatol. 2006, 18:332-341.
23. Brown MA: Genetics and the pathogenesis of ankylosing spondylitis, Curr. Opin. Rheumatol. 21 (2009) 318-323.
24. Breban M., Hammer R.E., Richardson J.A., et al. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J. Exp. Med. 1993, 178:1607-1616.
25. Mielants H., Veys E.M., Goemaere S., et al. A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology,. J. Rheumatol. 1993, 20:1353-1358.
26. Mielants H., Veys E.M., Cuvelier C., et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint,. J. Rheumatol. 1995, 22:2279-2284.
27. Colbert R.A. The immunobiology of HLA-B27: variations on a theme,. Curr. Mol. Med. 2004, 4:1-30.
28. Mear J.P., Schreiber K.L., Munz C., et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol. 1999, 163:6665-6670.
29. Turner M.J., Delay M.L., Bai S., et al. HLA-B27 upregulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondarthritis-like disease. Arthritis Rheum. 2007, 56:215-223.
30. Kapasi K., Inman R.D. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. J. Immunol. 1992, 148:3554-3559.
31. Ortiz-Alvarez O., Yu D.T., Petty R.E., et al. HLA-B27 does not affect invasion of arthritogenic bacteria into human cells. J. Rheumatol. 1998, 25:1765-1771.
32. Huppertz H.I., Heesemann J. Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27. Ann. Rheum. Dis. 1997, 56:671-676.
33. Granfors K. Host-microbe interaction in HLA-B27-associated diseases. Ann. Med. 1997, 29:153-157.
34. Benjamin M., McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies,. Adv. Exp. Med. Biol. 2009, 649:57-70.
35. Benjamin M., Toumi H., Suzuki D., et al. Microdamage and microvascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27 associated spondyloarthritides and related disorders. Arthritis Rheum. 2007, 56:224-233.
36. Brophy S., Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J. Rheumatol. 2001, 28:2283-2288.
37. van der Linden S.M., Valkenburg H.A., de Jongh B.M., et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population,. Arthritis Rheum. 1984, 27:241-249.
38. Reveille J.D. Recent studies on the genetic basis of ankylosing spondylitis. Cur. Rheum. Rep. 2009, 11:340-348.
39. Brown M.A. Progress in spondylarthritis: progress in studies of the genetics of ankylosing spondylitis. Arth. Res. 2009, 11:340-348.
40. Brown M.A. Genome-wide screening in ankylosing spondylitis. Adv. Exp. Med. Biol. 2009, 649:148-158.
41. Niepel G.A., Sit'aj S. Enthesopathy. Clin. Rheum. Dis. 1979, 5:857.
42. Burgos-Vargas R., Vazquez-Mellado J., Cassis N., et al. Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria. J. Rheumatol. 1996, 23:2140-2147.
43. Monnet D., Breban M., Hudry C., et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004, 111:802-809.
44. Huppertz H., Voigt I., Muller-Scholden J., et al. Cardiac manifestations in patients with HLA B27-associated juvenile arthritis. Pediatr. Cardiol. 2000, 21:141-147.
45. Stamato T., Laxer R.M., de Freitas C., et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am. J. Cardiol. 1995, 75:744-746.
46. Camiciottoli G., Trapani S., Ermini M., et al. Pulmonary function in children affected by juvenile spondyloarthropathy. J. Rheumatol. 1999, 26:1382-1386.
47. Foster H.E., Cairns R.A., Burnell R.H., et al. Atlantoaxial subluxation in children with seronegative enthesopathy and arthropathy syndrome: 2 case reports and a review of the literature. J. Rheumatol. 1995, 22:548-551.
48. Ball J. Pathology and pathogenesis. Ankylosing spondylitis 1980, Churchill Livingstone, Edinburgh. J.M.H. Moll (Ed.).
49. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann. Rheum. Dis. 1971, 30:213-223.
50. Macrae I.F., Wright V. Measurement of back movement. Ann. Rheum. Dis. 1969, 28:584-589.
51. Bellamy N., Park W., Rooney P.J. What do we know about the sacroiliac joint?. Semin. Arthritis Rheum. 1983, 12:282-313.
52. Azouz E.M., Duffy C.M. Juvenile spondyloarthropathies: clinical manifestations and medical imaging. Skeletal Radiol. 1995, 24:399-408.
53. Burgos-Vargas R., Vazquez-Mellado J., Pacheco-Tena C., et al. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies,. Ann. Rheum. Dis. 2002, 61:941-942.
54. Allen R.C., Gross K.R., Laxer R.M., et al. Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum. 1986, 29:997-1001.
55. Huppertz H.I., Tschammler A., Horwitz A.E., et al. Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J. Pediatr. 1995, 127:317-321.
56. Roychowdhury B., Bintley-Bagot S., Bulgen D.Y., et al. Is methotrexate effective in ankylosing spondylitis?. Rheumatology (Oxf.) 2002, 41:1330-1332.
57. Homeff G., Burgos-Vargas R. TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin. Exp. Rheumatol. 2002, 20:S137-S142.
58. Tse S.M.L., Burgos-Vargas R., Laxer R.M. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthriris Rheum. 2005, 52:2103-2108.
59. Calin A., Elswood J. The natural history of juvenile-onset ankylosing spondylitis: a 24-year retrospective case-control study,. Br. J. Rheumatol. 1998, 1(27):91-93.
60. Petty R.E., Southwood T.R., Manners P., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J. Rheumatol. 2004, 31:390-392.
61. Bennett P.H., Wood P.H.N. Population studies of the Rheumatic Diseases 1968, Excerpta Medica, New York.
62. Amor B., Dougados M., Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev. Rhum. Mal. Osteoartic. 1990, 57:85-89.
63. Dougados M., van der Linden L.S., Juhlin R., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34:1218-1227.
64. Moran H.M., Hall M.A., Barr A., et al. Spinal mobility in the adolescent. Rheumatol. Rehabil. 1979, 18:181-185.
65. Goie The H.S., Steven M.M., van der Linden S.M., et al. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br. J. Rheumatol. 1985, 24:242-249.
66. Petty R.E., Malleson P. Spondyloarthropathies of childhood. Pediatr. Clin. North Am. 1986, 33:1079-1096.
67. Burgos-Vargas R., Petty R.E. Juvenile ankylosing spondylitis. Rheum. Dis. Clin. North Am. 1992, 18:123-142.
68. Wright V., Moll J.M. Seronegative polyarthritis 1976, North Holland, Amsterdam, The Netherlands.
69. Rosenberg A.M., Petty R.E. A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis Rheum. 1982, 25:1041-1047.
70. Fink C.W. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J. Rheumatol. 1995, 22:1566-1569.
71. Petty R.E., Southwood T.R., Baum J., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban. J. Rheumatol. 1997, 25:1991-1994. 1998.
72. Cabral D.A., Oen K.G., Petty R.E. SEA syndrome revisited: a longterm followup of children with a syndrome of seronegative enthesopathy and arthropathy. J. Rheumatol. 1992, 19:1282-1285.
73. Burgos-Vargas R., Clark P. Axial involvement in the seronegative enthesopathy and arthropathy syndrome and its progression to ankylosing spondylitis. J. Rheumatol. 1989, 16:192-197.
74. Jacobs J.C., Berdon W.E., Johnston A.D. HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients. J. Pediatr. 1982, 100:521-528.
75. Cassidy J.T., Levinson J.E., Bass J.C., et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis,. Arthritis Rheum. 1986, 29:274-281.
76. Sheerin K.A., Giannini E.H., Brewer E.J., et al. HLA-B27-associated arthropathy in childhood: long-term clinical and diagnostic outcome. Arthritis Rheum. 1988, 31:1165-1170.
77. Hussein A., Abdul-Khaliq H. von der HH: Atypical spondyloarthritis in children: proposed diagnostic criteria. Eur. J. Pediatr. 1989, 148:513-517.
78. Prieur A.M., Listrat V., Dougados M., et al. Criteria for classification of spondylarthropathies in children. Arch. Fr. Pediatr. 1993, 50:379-385.
79. Bowyer S., Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J. Rheumatol. 1996, 23:1968-1974.
80. Malleson P.N., Fung M.Y., Rosenberg A.M. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry,. J. Rheumatol. 1996, 23:1981-1987.
81. Symmons D.P., Jones M., Osborne J., et al. Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J. Rheumatol. 1996, 23:1975-1980.
82. Andersson G.B., Fasth A., Andersson J., et al. Incidence and prevalence of juvenile chronic arthritis: a population survey. Ann. Rheum. Dis. 1987, 46:277-281.
83. Kaipiainen-Seppanen O., Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin. Exp. Rheumatol. 1996, 14:441-444.
84. Sauernmann R.K., Rose J.B., Tyrell P., et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 2007, 56:974-1984.
85. Gomez K.S., Raza K., Jones S.D., et al. Juvenile onset ankylosing spondylitis-more girls than we thought?. J. Rheumatol. 1997, 24:735-737.
86. Braun J., Bollow M., Remlinger G., et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 1998, 41:58-67.
87. Khan M.A. Update on spondyloarthropathies. Ann. Intern. Med. 2002, 136:896-907.
88. van der Linden L.S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27:361-368.
89. Carter E.T., McKenna C.H., Brian D.D., et al. Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935-1973. Arthritis Rheum. 1979, 22:365-370.
90. Carbone L.D., Cooper C., Michet C.J., et al. Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing?. Arthritis Rheum. 1992, 35:1476-1482.
91. Calin A. The epidemiology of ankylosing spondylitis 1984, Epidemiology of the rheumatic diseases: a clinician's point of view, New York, Gower. R.C. Lawrence, L.E. Shulman (Eds.).
92. Ladd J.R., Cassidy J.T., Martel W. Juvenile ankylosing spondylitis. Arthritis Rheum. 1971, 14:579-590.
93. Schaller J., Bitnum S., Wedgwood R.J. Ankylosing spondylitis with childhood onset. J. Pediatr. 1969, 74:505-516.
94. Bywaters E.G.L. Ankylosing spondylitis of childhood onset. Clin. Rheum. Dis. 1976, 2:387.
95. Sturrock R.D., Dick H.M., Henderson N. Association of HLA 27 in juvenile rheumatoid arthritis and ankylosing spondylitis. J. Rheumatol. 1974, 1:269.
96. Edmonds J., Morris R.I., Metzger A.L., et al. Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann. Rheum. Dis. 1974, 33:289-292.
97. Veys E.M., Coigne E., Mielants H., et al. HLA and juvenile chronic polyarthritis. Tissue Antigens 1976, 8:61-65.
98. Hafner R. Juvenile spondarthritis: retrospective study of 71 patients. Monatsschr. Kinderheilkd. 1987, 135:41-46.
99. Calin A., Fries J.F. Striking prevalence of ankylosing spondylitis in "healthy" w27 positive males and females. N. Engl. J. Med. 1975, 293:835-839.
100. Masi A.T., Walsh E.G. Ankylosing spondylitis: integrated clinical and physiological perspectives. Clin. Exp. Rheumatol. 2003, 21:1-8.
101. Resnick D., Dwosh I.L., Goergen T.G., et al. Clinical and radiographic abnormalities in ankylosing spondylitis: a comparison of men and women. Radiology 1976, 119:293-297.
102. Zeng Q.Y. Ankylosing spondylitis in Shantou, China: 15 years clinical experience. J. Rheumatol. 2003, 30:1816-1821.
103. Baum J., Ziff M. The rarity of ankylosing spondylitis in the black race,. Arthritis Rheum. 1971, 14:12-18.
104. Sonozaki H., Seki H., Chang S., et al. Human lymphocyte antigen, HL-A27, in Japanese patients with ankylosing spondylitis. Tissue Antigens 1975, 5:131-136.
105. Gofton J.P., Robinson H.S., Trueman G.E. Ankylosing spondylitis in a Canadian Indian population. Ann. Rheum. Dis. 1966, 25:525-527.
106. Good A.E., Kawanishi H., Schultz J.S. HLA B27 in blacks with ankylosing spondylitis or Reiter's disease [letter]. N. Engl. J. Med. 1976, 294:166-167.
107. Geczy A.F., Seager K., Bashir H.V., et al. The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II. Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis,. J. Clin. Lab. Immunol. 1980, 3:23-28.
108. Cameron F.H., Russell P.J., Easter J.F., et al. Failure of Klebsiella pneumoniae antibodies to cross-react with peripheral blood mononuclear cells from patients with ankylosing spondylitis. Arthritis Rheum. 1987, 30:300-305.
109. Kim T.-H., Uhm W.-S., Inman R.D. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr. Opin. Rheumatol. 2005, 17:400-405.
110. Pham T. Pathophysiology of ankylosing spondylitis: what's new?. Joint Bone Spine 2008, 75:656-660.
111. Sieper J. Developments in the scientific and clinical understanding of the spondyloarthritides. Arthritis Res. Therapy 2009, 11:208.
112. Reveille J.D. The genetic basis of ankylosing spondylitis,. Curr. Opin. Rheumatol. 2006, 18:332-341.
113. Brown MA: Genetics and the pathogenesis of ankylosing spondylitis, Curr. Opin. Rheumatol. 21 (2009) 318-323.
114. Hammer R.E., Maika S.D., Richardson J.A., et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.
115. Taurog J.D. Immunology, genetics, and animal models of the spondyloarthropathies. Curr. Opin. Rheumatol. 1990, 2:586-591.
116. Breban M., Hammer R.E., Richardson J.A., et al. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J. Exp. Med. 1993, 178:1607-1616.
117. Dominguez-Lopez M.L., Cancino-Diaz M.E., Jimenez-Zamudio L., et al. Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ ankylosing spondylitis. J. Rheumatol. 2000, 27:1453-1460.
118. Tiwana H., Natt R.S., Benitez-Brito R., et al. Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitis. Rheumatology (Oxf.) 2001, 40:15-23.
119. Mielants H., Veys E.M., Goemaere S., et al. A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology,. J. Rheumatol. 1993, 20:1353-1358.
120. Mielants H., Veys E.M., Cuvelier C., et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint,. J. Rheumatol. 1995, 22:2279-2284.
121. Mielants H., Veys E.M., Joos R., et al. HLA antigens in seronegative spondylarthropathies: reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation. J. Rheumatol. 1987, 14:466-471.
122. Jobanputra P., Choy E.H., Kingsley G.H., et al. Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitis. Ann. Rheum. Dis. 1992, 51:959-962.
123. Braun J., Bollow M., Neure L., et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995, 38:499-505.
124. Colbert R.A. The immunobiology of HLA-B27: variations on a theme,. Curr. Mol. Med. 2004, 4:1-30.
125. Mear J.P., Schreiber K.L., Munz C., et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J. Immunol. 1999, 163:6665-6670.
126. Turner M.J., Delay M.L., Bai S., et al. HLA-B27 upregulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondarthritis-like disease. Arthritis Rheum. 2007, 56:215-223.
127. Kapasi K., Inman R.D. HLA-B27 expression modulates gram-negative bacterial invasion into transfected L cells. J. Immunol. 1992, 148:3554-3559.
128. Kapasi K., Inman R.D. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. J. Immunol. 1994, 153:833-840.
129. Kapasi K., Inman R.D. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion. J. Immunol. 1994, 153:833-840.
130. Ortiz-Alvarez O., Yu D.T., Petty R.E., et al. HLA-B27 does not affect invasion of arthritogenic bacteria into human cells. J. Rheumatol. 1998, 25:1765-1771.
131. Huppertz H.I., Heesemann J. Invasion and persistence of Salmonella in human fibroblasts positive or negative for endogenous HLA B27. Ann. Rheum. Dis. 1997, 56:671-676.
132. Granfors K. Host-microbe interaction in HLA-B27-associated diseases. Ann. Med. 1997, 29:153-157.
133. Benjamin M., McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies,. Adv. Exp. Med. Biol. 2009, 649:57-70.
134. Benjamin M., Toumi H., Suzuki D., et al. Microdamage and microvascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27 associated spondyloarthritides and related disorders. Arthritis Rheum. 2007, 56:224-233.
135. Potocnik A.J., Menninger H., Yang S.Y., et al. Expression of the CD2 activation epitope T11-3 (CD2R) on T cells in rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and Lyme disease: phenotypic and functional analysis. Scand. J. Immunol. 1991, 34:351-358.
136. Grom A.A., Murray K.J., Luyrink L., et al. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy. Arthritis Rheum. 1996, 39:1703-1710.
137. Brophy S., Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J. Rheumatol. 2001, 28:2283-2288.
138. Ansell B.M., Bywaters E.G., Lawrence J.S. Familial aggregation and twin studies in Still's disease. Juvenile chronic polyarthritis. Rheumatology 1969, 2:37-61.
139. Rubin L.A., Amos C.I., Wade J.A., et al. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum. 1994, 37:1212-1220.
140. van der Linden S.M., Valkenburg H.A., de Jongh B.M., et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population,. Arthritis Rheum. 1984, 27:241-249.
141. Liu Y., Li J., Chen B., et al. Familial aggregation of ankylosing spondylitis in Southern China. J. Rheumatol. 2001, 28:550-553.
142. Baudoin P., van der Horst-Bruinsma I.E., Dekker-Saeys A.J., et al. Increased risk of developing ankylosing spondylitis among first-born children. Arthritis Rheum. 2000, 43:2818-2822.
143. T.K. Kvein, P. Moller, K. Dale, Juvenile ankylosing spondylitis and HLA B27 homosygosity, Scand. J. Rheumatol. 14 (1985) 47-50.
144. J. Hamersma, L.R. Cardon, L. Bradbury, et al., Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum. 44 (2001) 1396-1400.
145. W.P. Maksymowych, N. Adlam, D. Lind, et al., Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: no association with disease severity, Clin. Rheumatol. 16 (1997) 461-465.
146. Brown M.A., Kennedy L.G., MacGregor A.J., et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997, 40:1823-1828.
147. Oen K., Petty R.E., Schroeder M.L. An association between HLA-A2 and juvenile rheumatoid arthritis in girls. J. Rheumatol. 1982, 9:916-920.
148. Woodrow J.C. Ankylosing Spondylitis. Genetics 1980, Churchill Livingstone, Edinburgh. J.M.H. Moll (Ed.).
149. Arnett F.H., Schacter B.Z., Hochberg M.C., et al. HLA-A28 in patients with B27-associated rheumatic diseases. Arthritis Rheum. 1977, 20:106.
150. Calin A., Porta J., Payne R. HLA-A28 in B27 positive controls and patients with ankylosing spondylitis. Arthritis Rheum. 1977, 20:1428.
151. Robinson W.P., van der Linden S.M., Khan M.A., et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989, 32:1135-1141.
152. Brown M.A., Pile K.D., Kennedy L.G., et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis. 1996, 55:268-270.
153. Truog P., Steiger U., Contu I., et al. Ankylosing spondylitis (AS): a population and family study using HL-A serology and MLR. Histocompatibility testing 1975, Munksgaard, Copenhagen. F. Kissmeyer-Nielsen (Ed.).
154. van den Berg-Loonen E.M., Dekker-Saeys B.J., Meuwissen S.G., et al. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J. Immunogenet. 1977, 4:167-175.
155. McGarry F., Walker R., Sturrock R., et al. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27,. J. Rheumatol. 1999, 26:1110-1116.
156. McGarry F., Neilly J., Anderson N., et al. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis,. Rheumatology (Oxf.) 2001, 40:1359-1364.
157. Maksymowych W.P., Gorodezky C., Olivo A., et al. HLA-DRB1 08 influences the development of disease in Mexican Mestizo with spondyloarthropathy. J. Rheumatol. 1997, 24:904-907.
158. Maksymowych W.P., Jhangri G.S., Gorodezky C., et al. The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis,. Ann. Rheum. Dis. 1997, 56:488-492.
159. Ploski R., Flato B., Vinje O., et al. Association to HLA-DRB1 08, HLA-DPB1 0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum. Immunol. 1995, 44:88-96.
160. Reveille J.D. Recent studies on the genetic basis of ankylosing spondylitis. Cur. Rheum. Rep. 2009, 11:340-348.
161. Brown M.A. Progress in spondylarthritis: progress in studies of the genetics of ankylosing spondylitis. Arth. Res. 2009, 11:340-348.
162. Brown M.A. Genome-wide screening in ankylosing spondylitis. Adv. Exp. Med. Biol. 2009, 649:148-158.
163. Boyer G.S., Templin D.W., Bowler A., et al. Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations. J. Rheumatol. 1999, 26:1537-1544.
164. Baek H.J., Shin K.C., Lee Y.J., et al. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea. J. Rheumatol. 2002, 29:1780-1785.
165. Sherry D.D., Sapp L.R. Enthesalgia in childhood: site-specific tenderness in healthy subjects and in patients with seronegative enthesopathic arthropathy. J. Rheumatol. 2003, 30:1335-1340.
166. Niepel G.A., Sit'aj S. Enthesopathy. Clin. Rheum. Dis. 1979, 5:857.
167. Burgos-Vargas R., Pacheco-Tena C., Vazquez-Mellado J. A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies,. Clin. Exp. Rheumatol. 2002, 20:727-731.
168. Jimenez-Balderas F.J., Fernandez-Diez J., Fraga A. Tamale foot: deposit of acid mucopolysaccharides in the synovial sheaths of extensor tendons of the foot, resembling tendinitis, in a patient with juvenile ankylosing spondylitis. J. Rheumatol. 2000, 27:1788-1791.
169. Kleinman P., Rivelis M., Schneider R., et al. Juvenile ankylosing spondylitis. Radiology 1977, 125:775-780.
170. Burgos-Vargas R., Vazquez-Mellado J., Cassis N., et al. Genuine ankylosing spondylitis in children: a case-control study of patients with early definite disease according to adult onset criteria. J. Rheumatol. 1996, 23:2140-2147.
171. Petty R.E. Is ankylosing spondylitis in childhood a distinct entity?. J. Rheumatol. 1996, 23:2013-2014.
172. Monnet D., Breban M., Hudry C., et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004, 111:802-809.
173. Liao C.H., Huang J.L. Juvenile ankylosing spondylitis with uveitis. Asian. Pac. J. Allergy Immunol. 2003, 21:69-71.
174. Ansell B.M. Juvenile spondylitis and related disorders. Ankylosing spondylitis 1980, Churchill Livingstone, Edinburgh. J.M.H. Moll (Ed.).
175. Huppertz H., Voigt I., Muller-Scholden J., et al. Cardiac manifestations in patients with HLA B27-associated juvenile arthritis. Pediatr. Cardiol. 2000, 21:141-147.
176. Stewart S.R., Robbins D.L., Castles J.J. Acute fulminant aortic and mitral insufficiency in ankylosing spondylitis. N. Engl. J. Med. 1978, 299:1448-1449.
177. Reid G.D., Patterson M.W., Patterson A.C., et al. Aortic insufficiency in association with juvenile ankylosing spondylitis. J. Pediatr. 1979, 95:78-80.
178. Kean W.F., Anastassiades T.P., Ford P.M. Aortic incompetence in HLA B27-positive juvenile arthritis. Ann. Rheum. Dis. 1980, 39:294-295.
179. Gore J.E., Vizcarrondo F.E., Rieffel C.N. Juvenile ankylosing spondylitis and aortic regurgitation: a case presentation. Pediatrics 1981, 68:423-426.
180. Pelkonen P., Byring R., Pesonen E., et al. Rapidly progressive aortic incompetence in juvenile ankylosing spondylitis: a case report. Arthritis Rheum. 1984, 27:698-700.
181. Kim T.H., Jung S.S., Sohn S.J., et al. Aneurysmal dilatation of ascending aorta and aortic insufficiency in juvenile spondyloarthropathy. Scand. J. Rheumatol. 1997, 26:218-221.
182. Simpson J., Borzy M.S., Silberbach G.M. Aortic regurgitation at diagnosis of HLA-B27 associated spondyloarthropathy. J. Rheumatol. 1995, 22:332-334.
183. Johnson W.L., Toone E. The clinical and pathological cardiac manifestations of rheumatoid spondylitis. Va. Med. Mon. (1918) 1968, 95:132-140.
184. Lee S.J., Im H.Y., Schueller W.C. HLA-B27 positive juvenile arthritis with cardiac involvement preceding sacroiliac joint changes. Heart 2001, 86:E19.
185. Stamato T., Laxer R.M., de Freitas C., et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am. J. Cardiol. 1995, 75:744-746.
186. Roldan C.A., Chavez J., Wiest P.W., et al. Aortic root disease and valve disease associated with ankylosing spondylitis. J. Am. Coll. Cardiol. 1998, 32:1397-1404.
187. Camiciottoli G., Trapani S., Ermini M., et al. Pulmonary function in children affected by juvenile spondyloarthropathy. J. Rheumatol. 1999, 26:1382-1386.
188. Rosenow E., Strimlan C.V., Muhm J.R., et al. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo. Clin. Proc. 1977, 52:641-649.
189. Fenlon H.M., Casserly I., Sant S.M., et al. Plain radiographs and thoracic high-resolution CT in patients with ankylosing spondylitis. AJR. Am. J. Roentgenol. 1997, 168:1067-1072.
190. Reid G.D., Hill R.H. Atlantoaxial subluxation in juvenile ankylosing spondylitis. J. Pediatr. 1978, 93:531-532.
191. Foster H.E., Cairns R.A., Burnell R.H., et al. Atlantoaxial subluxation in children with seronegative enthesopathy and arthropathy syndrome: 2 case reports and a review of the literature. J. Rheumatol. 1995, 22:548-551.
192. Bartleson J.D., Cohen M.D., Harrington T.M., et al. Cauda equina syndrome secondary to long-standing ankylosing spondylitis. Ann. Neurol. 1983, 14:662-669.
193. Allen R.C., Petty R.E., Lirenman D.S., et al. Renal papillary necrosis in children with chronic arthritis. Am. J. Dis. Child 1986, 140:20-22.
194. Mustonen J. IgA glomerulonephritis and associated diseases. Ann. Clin. Res. 1984, 16:161-166.
195. Bruneau C., Villiaumey J., Avouac B., et al. Seronegative spondyloarthropathies and IgA glomerulonephritis: a report of four cases and a review of the literature. Semin. Arthritis Rheum. 1986, 15:179-184.
196. Julkunen H. Synovial inflammatory cell reaction in chronic arthritis. Acta. Rheumatol. Scand. 1966, 12:188-196.
197. Shichikawa K., Tsujimoto M., Nishioka J., et al. Histopathology of early sacroiliitis and enthesitis in ankylosing spondylitis. Adv. Inflammat. Res. 1985, 9:15.
198. Ball J. Pathology and pathogenesis. Ankylosing spondylitis 1980, Churchill Livingstone, Edinburgh. J.M.H. Moll (Ed.).
199. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann. Rheum. Dis. 1971, 30:213-223.
200. Lehman T.J., Hanson V., Kornreich H., et al. HLA-B27-negative sacroiliitis: a manifestation of familial Mediterranean fever in childhood. Pediatrics 1978, 61:423-426.
201. Sherry D.D., Petty R.E., Tredwell S., et al. Histocompatibility antigens in Osgood-Schlatter disease. J. Pediatr. Orthop. 1985, 5:302-305.
202. Olivieri I., Barbieri P., Gemignani G., et al. Isolated juvenile onset HLA-B27 associated peripheral enthesitis. J. Rheumatol. 1990, 17:567-568.
203. Bowyer S. Hip contracture as the presenting sign in children with HLA-B27 arthritis. J. Rheumatol. 1995, 22:165-167.
204. Burgos-Vargas R., Naranjo A., Castillo J., et al. Ankylosing spondylitis in the Mexican mestizo: patterns of disease according to age at onset. J. Rheumatol. 1989, 16:186-191.
205. Maghraoui A.E., Bensabbah R., Bahiri R., et al. Cervical spine involvement in ankylosing spondylitis. Clin. Rheumatol. 2003, 22:94-98.
206. Macrae I.F., Wright V. Measurement of back movement. Ann. Rheum. Dis. 1969, 28:584-589.
207. Moll J.M., Wright V. Normal range of spinal mobility: an objective clinical study. Ann. Rheum. Dis. 1971, 30:381-386.
208. Barkley D.O., Hohermuth H.J., Howard A., et al. IgA deficiency in juvenile chronic polyarthritis. J. Rheumatol. 1979, 6:219-224.
209. Cassidy J.T. Selective IgA deficiency and chronic arthritis in children. Ross Laboratories 1981, Arthritis in childhood: report of the Eightieth Ross Conference in Pediatric Research, Columbus, OH. T.D. Moore (Ed.).
210. Kinsella T.D., Espinoza L., Vasey F.B. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. J. Rheumatol. 1975, 2:308-313.
211. Cowling P., Ebringer R., Ebringer A. Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann. Rheum. Dis. 1980, 39:545-549.
212. Corrigall V., Panayi G.S., Unger A., et al. Detection of immune complexes in serum of patients with ankylosing spondylitis. Ann. Rheum. Dis. 1978, 37:159-163.
213. Juanola X., Mateo L., Domenech P., et al. Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis. J. Rheumatol. 1995, 22:1891-1893.
214. Kendall M.J., Farr M., Meynell M.J., et al. Synovial fluid in ankylosing spondylitis. Ann. Rheum. Dis. 1973, 32:487-492.
215. Traycoff R.B., Pascual E., Schumacher H.R. Mononuclear cells in human synovial fluid. Identification of lymphoblasts in rheumatoid arthritis. Arthritis Rheum. 1976, 19:743-748.
216. Spriggs A.I., Boddington M.M., Mowat A.G. Joint fluid cytology in Reiter's disease. Ann. Rheum. Dis. 1978, 37:557-560.
217. Bunch T.W., Hunder G.G., McDuffie F.C., et al. Synovial fluid complement determination as a diagnostic aid in inflammatory joint disease. Mayo. Clin. Proc. 1974, 49:715-720.
218. Bellamy N., Park W., Rooney P.J. What do we know about the sacroiliac joint?. Semin. Arthritis Rheum. 1983, 12:282-313.
219. Kurugoglu S., Kanberoglu K., Kanberoglu A., et al. MRI appearances of inflammatory vertebral osteitis in early ankylosing spondylitis. Pediatr. Radiol. 2002, 32:191-194.
220. Rudwaleit M., Jurik A.G., Hermann K.G., et al. et al Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach. Ann. Rheum. Dis. 2009, 68:520-527.
221. Bollow M., Biedermann T., Kannenberg J., et al. Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides. J. Rheumatol. 1998, 25:556-564.
222. Brophy S., Mackay K., Al Saidi A., et al. The natural history of ankylosing spondylitis as defined by radiological progression,. J. Rheumatol. 2002, 29:1236-1243.
223. Lee H.S., Kim T.H., Yun H.R., et al. Radiologic changes of cervical spine in ankylosing spondylitis. Clin. Rheumatol. 2001, 20:262-266.
224. Azouz E.M., Duffy C.M. Juvenile spondyloarthropathies: clinical manifestations and medical imaging. Skeletal Radiol. 1995, 24:399-408.
225. O'Shea F.D., Boyle E., Riarh R., et al. Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis. Ann. Rheum. Dis. 2009, 68:407-412.
226. Averns H.L., Oxtoby J., Taylor H.G., et al. Smoking and outcome in ankylosing spondylitis,. Scand. J. Rheumatol. 1996, 25:138-142.
227. Burgos-Vargas R., Vazquez-Mellado J., Pacheco-Tena C., et al. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies,. Ann. Rheum. Dis. 2002, 61:941-942.
228. Dougados M., Boumier P., Amor B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br. Med. J. (Clin. Res. Ed.) 1986, 293:911-914.
229. Dougados M., Maetzel A., Mijiyawa M., et al. Evaluation of sulphasalazine in the treatment of spondyloarthropathies. Ann. Rheum. Dis. 1992, 51:955-958.
230. Nissila M., Lehtinen K., Leirisalo-Repo M., et al. Sulfasalazine in the treatment of ankylosing spondylitis: a twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum. 1988, 31:1111-1116.
231. Davis M.J., Dawes P.T., Beswick E., et al. Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin. Br. J. Rheumatol. 1989, 28:410-413.
232. Fraser S.M., Sturrock R.D. Evaluation of sulphasalazine in ankylosing spondylitis-an interventional study. Br. J. Rheumatol. 1990, 29:37-39.
233. Corkill M.M., Jobanputra P., Gibson T., et al. A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect,. Br. J. Rheumatol. 1990, 29:41-45.
234. Ansell B.M., Hall M.A., Loftus J.K., et al. A multicentre pilot study of sulphasalazine in juvenile chronic arthritis,. Clin. Exp. Rheumatol. 1991, 9:201-203.
235. Suschke H.J. Therapy of juvenile chronic arthritis with sulfasalazine. Z. Rheumatol. 1987, 46:83-85.
236. Joos R., Veys E.M., Mielants H., et al. Sulfasalazine treatment in juvenile chronic arthritis: an open study. J. Rheumatol. 1991, 18:880-884.
237. Huang J.L., Chen L.C. Sulphasalazine in the treatment of children with chronic arthritis. Clin. Rheumatol. 1998, 17:359-363.
238. Miller J.J. III: Prolonged use of large intravenous steroid pulses in the rheumatic diseases of children. Pediatrics 1980, 65:989-994.
239. Allen R.C., Gross K.R., Laxer R.M., et al. Intraarticular triamcinolone hexacetonide in the management of chronic arthritis in children. Arthritis Rheum. 1986, 29:997-1001.
240. Huppertz H.I., Tschammler A., Horwitz A.E., et al. Intraarticular corticosteroids for chronic arthritis in children: efficacy and effects on cartilage and growth. J. Pediatr. 1995, 127:317-321.
241. Braun J., Bollow M., Seyrekbasan F., et al. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. J. Rheumatol. 1996, 23:659-664.
242. Creemers M.C., Franssen M.J., van de Putte L.B., et al. Methotrexate in severe ankylosing spondylitis: an open study. J. Rheumatol. 1995, 22:1104-1107.
243. Roychowdhury B., Bintley-Bagot S., Bulgen D.Y., et al. Is methotrexate effective in ankylosing spondylitis?. Rheumatology (Oxf.) 2002, 41:1330-1332.
244. Homeff G., Burgos-Vargas R. TNF-alpha antagonists for the treatment of juvenile-onset spondyloarthritides. Clin. Exp. Rheumatol. 2002, 20:S137-S142.
245. Davis J.C., van der H.D., Braun J., et al. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum. 2003, 48:3230-3236.
246. Gorman J.D., Sack K.E., Davis J.C. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N. Engl. J. Med. 2002, 346:1349-1356.
247. Braun J., Brandt J., Listing J., et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002, 359:1187-1193.
248. Tse S.M.L., Burgos-Vargas R., Laxer R.M. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthriris Rheum. 2005, 52:2103-2108.
249. Maksymowych W.P., Jhangri G.S., Fitzgerald A.A., et al. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis,. Arthritis Rheum. 2002, 46:766-773.
250. Sochart D.H., Porter M.L. Long-term results of total hip replacement in young patients who had ankylosing spondylitis: eighteen to thirty-year results with survivorship analysis. J. Bone Joint Surg. Am. 1997, 79:1181-1189.
251. Lehtimaki M.Y., Lehto M.U., Kautiainen H., et al. Charnley total hip arthroplasty in ankylosing spondylitis: survivorship analysis of 76 patients followed for 8-28 years. Acta. Orthop. Scand. 2001, 72:233-236.
252. Calin A., Elswood J. The natural history of juvenile-onset ankylosing spondylitis: a 24-year retrospective case-control study,. Br. J. Rheumatol. 1998, 1(27):91-93.
253. Garcia-Morteo O., Maldonado-Cocco J.A., Suarez-Almazor M.E., et al. Ankylosing spondylitis of juvenile onset: comparison with adult onset disease. Scand. J. Rheumatol. 1983, 12:246-248.
254. Burgos-Vargas R., Vazquez-Mellado J. Cohort study comparing juvenile ankylosing spondylitis (JAS) and juvenile rheumatoid arthritis (JRA). J. Rheumatol. 1992, 19(suppl. 33):118.
255. Marks S.H., Barnett M., Calin A. A case-control study of juvenile- and adult-onset ankylosing spondylitis,. J. Rheumatol. 1982, 9:739-741.